Latest Trials

Systemic therapy trial

A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of...

This phase I trial is trying to determine the dose of two combined oral therapies (ipatasertib and rucaparib) as a treatment for advanced breast, ovarian or prostate cancer

Status : Recruiting

Systemic therapy trial

A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic...

This phase I/II trial is trying measure the dose of a new oral therapy (LOXO-305) as a treatment for people with Chronic Lymphocytic Leukaemia (CLL), Small Lymphocytic Leukaemia (SLL) or B-Cell Non-Hodgkin Lymphoma who have failed or unable to receive standard of care

Status : Recruiting

Systemic therapy trial

A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and...

This phase I trial is trying to measure the dose of a new oral therapy (JNJ-67856633) as a possible treatment for people with B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia, who have gotten worse or not responded to other treatments

Status : Recruiting

Systemic therapy trial

A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan...

This phase III trial is trying to determine how safe and effective the drug Uproleselan is, when given in combination with chemotherapy, in the treatment of Acute Myeloid Leukaemia that has gotten worse or not responded to prior therapy

Status : Recruiting

Systemic therapy trial

LEAP-007 : A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) With or Without...

This phase III trial is evaluating the safety and effectiveness of a type of immunotherapy (Pembrolizumab) alone and in combination with an oral targeted therapy (Lenvatinib) in patients who have received no prior treatment for metastatic non-small cell lung cancer

Status : Recruiting

Systemic therapy trial

POTOMAC : A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab and Bacillus...

This phase III trial is trying to determine whether the combination of an immunotherapy (Durvalumab) and a standard of care therapy (Bacillus Calmette-Guerin) is better than giving standard of care therapy alone, in the treatment of non-muscle-invasive bladder cancer

Status : Recruiting

Systemic therapy trial

A Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus...

This phase II trial is evaluating a biological therapy (Tavokinogene Telseplasmid - delivered by electroporation), in combination with an immunotherapy drug (Pembrolizumab), in patients with advanced triple negative breast cancer

Status : Recruiting

Systemic therapy trial

ATTAIN : A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of...

This phase III trial is comparing the drug NKTR-102 with a treatment chosen by the doctor in patients who have have been treated for breast cancer that has spread to the brain

Status : Recruiting

Systemic therapy trial

ZUMA-7 : A Phase 3, Randomized, Open-Label Study Evaluating Efficacy of Axicabtagene Ciloleucel...

This phase III trial is comparing the effectiveness of a biological therapy (Axicabtagene Ciloleucel) and standard of care chemotherapy in Diffuse Large B-Cell Lymphoma patients who have gotten worse or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients With Relapsed...

This phase I trial is testing escalating doses of a new oral therapy (RP4010) in lymphoma patients who have gotten worse or not responded to prior treatment

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.